Pfizer (PFE) trades at $26.18 with a 24/7 Wall St. price target of $32.92, implying 25.76% upside, driven by non-COVID revenue growth of 9% in Q4 with Abrysvo rising 136% and Eliquis up 10%, while adjusted EPS beat at $0.66 versus $0.57 consensus.
Vandita Jadeja is a Contributor at various financial platforms. With over a decade of experience in financial journalism, she specializes in areas such as investment strategies, asset management, and personal finance, while also covering tech and e-commerce topics. Her insightful work has been featured in notable publications including Business Insider, InvestorPlace, and Yahoo Finance.



